
Immunodiagnostic Systems Holdings PLC – LSE:IDH.L
Immunodiagnostic Systems Holdings stock price today
Immunodiagnostic Systems Holdings stock price monthly change
Immunodiagnostic Systems Holdings stock price quarterly change
Immunodiagnostic Systems Holdings stock price yearly change
Immunodiagnostic Systems Holdings key metrics
Market Cap | 1 |
Enterprise value | N/A |
P/E | N/A |
EV/Sales | N/A |
EV/EBITDA | N/A |
Price/Sales | N/A |
Price/Book | N/A |
PEG ratio | N/A |
EPS | 0.09 |
Revenue | 39.13M |
EBITDA | 7.45M |
Income | 2.71M |
Revenue Q/Q | N/A |
Revenue Y/Y | N/A |
Profit margin | 8.51% |
Oper. margin | 3.38% |
Gross margin | 44.16% |
EBIT margin | 3.38% |
EBITDA margin | 19.05% |
create your own Smart Feed
Personalize your watchlist with companies you want to keep track of and get notified in the smart feed every time fresh news arrives.
Sign up for freeImmunodiagnostic Systems Holdings stock price history
Immunodiagnostic Systems Holdings stock forecast
Immunodiagnostic Systems Holdings financial statements
Jun 2019 | 9.62M | 199K | 2.07% |
---|---|---|---|
Mar 2020 | 9.83M | 837K | 8.51% |
Jun 2020 | 9.83M | 837K | 8.51% |
Sep 2020 | 9.83M | 837K | 8.51% |
Payout ratio | 0% |
---|
2012 | 0.01% |
---|---|
2016 | |
2017 | |
2019 | |
2020 |
Mar 2019 | 65919000 | 10.61M | 16.1% |
---|---|---|---|
Sep 2019 | 68154000 | 11.41M | 16.75% |
Mar 2020 | 73307000 | 16.21M | 22.12% |
Sep 2020 | 67798000 | 13.81M | 20.37% |
Jan 2020 | 1.38M | -1.20M | -50.25K |
---|---|---|---|
Mar 2020 | 1.38M | -1.20M | -50.25K |
Jun 2020 | 1.38M | -1.20M | -50.25K |
Sep 2020 | 1.38M | -1.20M | -50.25K |
Immunodiagnostic Systems Holdings other data
-
What's the price of Immunodiagnostic Systems Holdings stock today?
One share of Immunodiagnostic Systems Holdings stock can currently be purchased for approximately $378.
-
When is Immunodiagnostic Systems Holdings's next earnings date?
Unfortunately, Immunodiagnostic Systems Holdings's (IDH.L) next earnings date is currently unknown.
-
Does Immunodiagnostic Systems Holdings pay dividends?
No, Immunodiagnostic Systems Holdings does not pay dividends.
-
How much money does Immunodiagnostic Systems Holdings make?
Immunodiagnostic Systems Holdings has a market capitalization of 1 and it's past years’ income statements indicate that its last revenue has increased compared to the previous period by 1.49% to 38.51M US dollars.
-
What is Immunodiagnostic Systems Holdings's stock symbol?
Immunodiagnostic Systems Holdings PLC is traded on the LSE under the ticker symbol "IDH.L".
-
What is Immunodiagnostic Systems Holdings's primary industry?
Company operates in the Healthcare sector and Medical Devices industry.
-
How do i buy shares of Immunodiagnostic Systems Holdings?
Shares of Immunodiagnostic Systems Holdings can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.
-
How many employees does Immunodiagnostic Systems Holdings have?
Immunodiagnostic Systems Holdings PLC employs 276 workers.
-
When Immunodiagnostic Systems Holdings went public?
Immunodiagnostic Systems Holdings PLC is publicly traded company for more then 20 years since IPO on 24 Dec 2004.
-
What is Immunodiagnostic Systems Holdings's official website?
The official website for Immunodiagnostic Systems Holdings is idsplc.com.
-
Where are Immunodiagnostic Systems Holdings's headquarters?
Immunodiagnostic Systems Holdings is headquartered at 10 Didcot Way, The Boldons, TYNE AND WEAR.
-
How can i contact Immunodiagnostic Systems Holdings?
Immunodiagnostic Systems Holdings's mailing address is 10 Didcot Way, The Boldons, TYNE AND WEAR and company can be reached via phone at +44 191 519 0660.
Immunodiagnostic Systems Holdings company profile:

Immunodiagnostic Systems Holdings PLC
idsplc.comLSE
276
Medical Devices
Healthcare
Immunodiagnostic Systems Holdings PLC develops, manufactures, and sells in-vitro diagnostic tests to the clinical laboratory market in the United Kingdom, the United States, Germany, France, and internationally. It develops, manufactures, and markets immunoassays and automated immunoanalyser technologies to provide diagnostic outcomes for patients. It offers IDS-iSYS multi-discipline automated systems, which is based on chemiluminescence and absorbency technology is used for immunoassay testing. The company provides its products and services for diagnosis of bone metabolism, calcium metabolism, hypertension, chronic kidney disease mineral bone disorder, growth, fertility, autoimmunity, infectious disease, sarcoidosis, and allergy. Immunodiagnostic Systems Holdings PLC was founded in 1977 and is headquartered in Boldon, the United Kingdom.
The Boldons, TYNE AND WEAR
:
ISIN: GB00B01YZ052
CUSIP: G4762F109